MICHAEL BYRON WEBB
No ORCID on file
· 2 papers in corpus
· active 2009
Frequent coauthors
2009
Compounds of the structure (I) are described, wherein R 1 , R 2 , R 5 , R 6 , V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful for treating a v…
2009
Compounds of the structure (I) are described, wherein R 1 , R 2 , R 5 , R 6 , V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful for treating a v…